Searched for
ZYDUS COVID VACCINE
Production ramp up delayed Zydus Cadila’s vaccine launch, roll out likely soonZydus had received an order from the government to supply 10 million doses of ZyCoV-D, the world's first plasmid DNA vaccine, at ₹265 per d...- Zydus Cadila's ZyCov-D shot to soon join other vaccines in India's Covid fightThe drug regulator had on August 20 given emergency use authorisation (EUA) to the three-dose Covid-19 vaccine, the first in India that can...
- Zydus Cadila's Covid vaccine to be administered only to adults as of now: SourcesZydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be a...
- Zydus Cadila to get clarity on ZyCoV-D Covid vaccine pricing in 1-2 weeks: MD Sharvil PatelOn Sunday, news wire PTI reported, citing government sources, that the company had agreed to bring down the price of ZyCov-D to ₹265 a dose...
- Right pricing to hold the key for Zydus Cadila's vaccine launchZydus Cadila has the drug regulator's emergency use authorisation to administer its Covid vaccine, ZyCoV-D, in children aged 12-18 years. A...
- Zydus Cadila gets permission to conduct phase III trial for two-dose Covid vaccineThe drug regulator had approved Zydus’ vaccine on August 20 for emergency use in India.
- Zydus vaccine likely to cost Rs 300 a doseHealth secretary Rajesh Bhushan on Thursday had spoken about the pricing. "We are in conversation with the manufacturer. Since it is a thre...
- Government lab releases first batch of Zydus Cadila's covid vaccine ZyCoV-DNeedle-free ZyCoV-D, manufactured by Ahmedabad-based Zydus Cadila, is the first Covid-19 vaccine approved for the 12 to 18 years age group ...
- Zydus jab likely to cost more than Covishield, pricing to be out soonZydus Cadila's Covid vaccine, which is likely to be launched next month, may cost more than Covishield but will be comparable with those al...
- Hope to start supply of ZyCoV-D vaccine by mid to end September: Zydus Group MD"Post the emergency use authorisation, now we will work closely with the regulatory authorities to work on the pricing and modality of deli...
- Drug regulator okays Zydus Cadila's three-dose Covid vaccine, first in India to be given to kids above 12The Indian drug regulator has given emergency use authorisation (EUA) to Zydus Cadila's three-dose Covid-19 vaccine, the ministry of scienc...
- PM Modi lauds India's scientists for developing Zydus Cadila's DNA-based Covid vaccine ZyCoV-DThe Prime Minister tweeted saying that India is resolutely fighting the Covid battle and the approval of the world's first DNA-based vaccin...
- India okays Zydus Cadila's DNA-based Covid vaccine, first to be given to kids above 12Earlier, an expert panel of India's central drug authority has recommended granting emergency use authorisation to Zydus Cadila's three-dos...
- India to take up Zydus’ COVID vaccine EUA applicationIndia’s drug regulatory authority is likely to take up Zydus Cadila's application seeking Emergency Use Authorisation (EUA) for its Covid-1...
- Zydus Cadila likely to get emergency use approval for its COVID vaccine this week: SourcesZydus Cadila last month had said that it has applied for emergency use authorisation (EUA) with the Indian Drug regulator for its three-dos...
- DNA-based coronavirus vaccine: What is it and how does it work?While still in early stages, this technology has been developed rapidly by experts and if approved, the vaccine developed by India's Zydus ...
- ‘Cadila vaccine found to be safe for children aged 12-18 years’The Ahmedabad-based company is carrying out clinical trials involving 1,000 children to test the efficacy of its vaccine against SARS-CoV-2...
- Cadila Healthcare gains 3% as DCGI plays phase III trials of Covid vaccineThe company will now be initiating Phase III clinical trials in around 30,000 volunteers.
- Bharat Biotech starts human trial of its anti-COVID vaccine at PGI Rohtak: Minister Vij“Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today,” Vij, who is also the Home and Science & Technolo...
- Human trials of COVID-19 vaccine candidate important milestone for Atmanirbhar Bharat: DBTZydus Cadila's move to begin human trials of its indigenously developed vaccine candidate for COVID-19 is an important milestone for an 'At...
Load More
